# Timed Release Tablet Prednisone in Polymyalgia Rheumatica

> **NCT00836810** · PHASE2,PHASE3 · COMPLETED · sponsor: **University Hospitals Bristol and Weston NHS Foundation Trust** · enrollment: 12 (actual)

## Conditions studied

- Polymyalgia Rheumatica

## Interventions

- **DRUG:** Timed Release Tablet Prednisone
- **DRUG:** Prednisolone

## Key facts

- **NCT ID:** NCT00836810
- **Lead sponsor:** University Hospitals Bristol and Weston NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-11
- **Final completion:** 2011-03
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00836810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00836810, "Timed Release Tablet Prednisone in Polymyalgia Rheumatica". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00836810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*